(Press-News.org) FOR EMBARGOED RELEASE
Wednesday, Sept. 10, 2025
5 p.m. EDT
Contact: NIH Office of Communications
301-496-5787
Treating opioid addiction in jails improves treatment engagement, reduces overdose deaths and reincarceration
NIH-funded study demonstrates life-saving potential of providing medications for opioid use disorder in carceral settings
A study supported by the National Institutes of Health (NIH) finds that individuals who received medication for opioid use disorder (MOUD) while incarcerated were significantly more likely to continue treatment six months after release than those who did not receive MOUD. The study also found that receiving MOUD in jail was associated with a 52% lower risk of fatal opioid overdose, a 24% lower risk of non-fatal opioid overdose, a 56% lower risk of death from any cause, and a 12% lower risk of reincarceration after release. These outcomes underscore the importance of providing MOUD treatment during incarceration.
Published in The New England Journal of Medicine, the study analyzed data from 6,400 people with probable opioid use disorder who were incarcerated in seven Massachusetts county jails between September 2019 and December 2020. Of these, 42% received MOUD while in jail, while 58% did not. Researchers monitored treatment engagement, opioid overdose, reincarceration, and mortality for all participants for up to six months after release.
“These findings demonstrate the importance of providing medications to treat opioid use disorder in correctional settings,” said Nora D. Volkow, M.D., Director of NIDA. “Offering effective opioid treatment to people in jail is a critical step toward addressing the opioid crisis, promoting recovery, saving lives and reducing reincarceration. It’s a win-win for public health.”
The opioid epidemic remains a devastating public health challenge in the United States, contributing to more than 80,000 deaths in 2024 alone. People with opioid use disorder are overrepresented in jails compared to the general population. Despite their effectiveness, MOUD is available in only about 13% of U.S. jails and is often restricted to specific groups, such as pregnant women. This limited access contributes to forced withdrawal, increasing the risk of relapse and overdose post-release.
Massachusetts has been especially impacted by the overdose epidemic, with fatal opioid-related overdoses quadrupling over the past two decades. In response, a 2018 state law mandated a four-year pilot program to provide all U.S. Food and Drug Administration-approved MOUD—buprenorphine, methadone, and naltrexone—in five county jails, with two additional jails voluntarily joining the program. The law requires that individuals already receiving treatment for opioid use disorder continue it during detention, begin treatment before release when appropriate, and be connected to community care after release.
To evaluate the impact of the pilot program, the Massachusetts Department of Public Health partnered with the Massachusetts Justice Community Opioid Innovation Network (MassJCOIN) and participating jails to conduct a comprehensive study tracking post-release outcomes. Researchers collected data directly from incarcerated individuals and extracted information from jail administrative and clinical records. These data were integrated with the Massachusetts Public Health Data Warehouse, which links over 35 state databases to track treatment for substance use disorders, incarceration, mortality, and other public health indicators. This linkage enabled a robust analysis of the program’s impact on key post-release outcomes.
Treatment in jail was strongly associated with better outcomes after release. Within the first 30 days, 60.2% of those who received MOUD in jail, initiated treatment in the community, compared to only 17.6% of individuals who weren’t treated. Half of the group treated in jail stayed on medication for at least 75% of the first 90 days after release, while only 12.3% of the untreated group did the same. Six months after release, 57.5% of those who received treatment in jail continued receiving MOUD, compared to just 22.8% of those who did not. Most people treated in jail received buprenorphine (67.9%) followed by methadone (25.7%) and naltrexone (6.5%).
“The Massachusetts initiative represents a model for how jails can play a vital role in addressing the opioid epidemic in the community,” said Peter D. Friedmann, M.D., M.P.H., lead author and addiction medicine physician at the University of Massachusetts Chan Medical School. Senior author Elizabeth A. Evans, PhD, a public health professor from University of Massachusetts-Amherst added, “Establishing these types of programs in local jails is a powerful and effective strategy for engaging and retaining people in treatment and reducing overdose deaths after release.”
Future research should explore the generalizability of these findings to other correctional systems, as well as how outcomes differ across population subgroups and by the type of medication received. Research to examine which strategies for implementing MOUD in jails are most effective in supporting recovery after release are also needed.
This research was supported by the Justice Community Opioid Innovation Network (JCOIN), a nationwide research program that tests strategies to expand effective treatment, recovery, and related services for individuals with opioid use disorder involved in the criminal justice system. JCOIN is funded by the NIH’s National Institute on Drug Abuse as part of the NIH Helping to End Addiction Long-term ® (NIH HEAL Initiative®).
---------------------------------------------
For more information on substance and mental health treatment programs in your area, call the free and confidential National Helpline 1-800-662-HELP (4357) or visit FindTreatment.gov. Anyone who needs assistance with the first steps in pursuing help can find guidance at FindSupport.gov.
Reference: PD Friedmann, et al. Medications for Opioid Use Disorder in County Jails: Outcomes After Release. New England Journal of Medicine. DOI: 10.1056/NEJMsa2415987 (2025).
###
About the National Institute on Drug Abuse (NIDA): NIDA is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. For more information about NIDA and its programs, visit www.nida.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH…Turning Discovery Into Health®
END
Treating opioid addiction in jails improves treatment engagement, reduces overdose deaths and reincarceration
NIH-funded study demonstrates life-saving potential of providing medications for opioid use disorder in carceral settings
2025-09-10
ELSE PRESS RELEASES FROM THIS DATE:
Can’t sleep? Insomnia associated with accelerated brain aging
2025-09-10
EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, WEDNESDAY, SEPTEMBER 10, 2025
Highlights:
Chronic insomnia—trouble sleeping at least three days a week for three months or more—could speed up brain aging.
People with chronic insomnia were 40% more likely to develop dementia or mild cognitive issues than people without insomnia.
Insomnia with perceived reduced sleep was associated with lower cognition comparable to being four years older.
Better sleep isn’t just beauty rest—it might protect your brain health.
MINNEAPOLIS — People with chronic insomnia may ...
Study links teacher turnover to higher rates of student suspensions, disciplinary referrals
2025-09-10
Studies show that teacher turnover has a negative impact on students’ academic performance, but little is known about other ways that their departures affect student behavior. In a new study of New York City public schools, researchers found that teacher turnover is linked to higher rates of student suspensions and requests from teachers seeking disciplinary action, known as office disciplinary referrals (ODR).
“Teacher turnover has generally been studied for its impact on student achievement, but there are a host of reasons to expect that turnover, which creates disruption and instability, would also lead to more disciplinary infractions and suspensions,” says lead author Luis ...
How harmful bacteria hijack crops
2025-09-10
By Chris Woolston
Aphids, grasshoppers and other bugs aren’t the only pests that can quickly wipe out a crop. Many harmful bacteria have evolved ways to bypass a plant’s defenses. A once-healthy tomato plant can quickly turn sick and blotchy, thanks to microscopic foes armed with an arsenal of tricks.
In a recent study, researchers at Washington University in St. Louis have identified a tool that helps the bacteria Pseudomonas syringae turn a plant’s fundamental biology against itself. The findings, recently published in the prestigious journal mBio, could eventually lead to new approaches to protecting crops, said co-author Barbara Kunkel, ...
Crowded conditions muddle frogs’ mating choices
2025-09-10
Female treefrogs prefer a mate with an impressive call, but the crowded environments give unattractive males an edge, according to a new international study led by Assistant Professor Jessie Tanner of the University of Tennessee, Knoxville.
When choosing among only two males, female gray treefrogs pick the mate with faster and more regular calls. Faced with four or eight types of calls, however, their choices were inconsistent, according to the study recently published in the biological sciences journal Proceedings of the Royal Society B.
In the wild, frogs usually are choosing mates in noisy, crowded environments called choruses, with many males calling at the same ...
A new way to guide light, undeterred
2025-09-10
Key Takeaways
Penn researchers built a light-based crystal “tunnel” that forces light to move one way, even around bumps, bends, and defects.
By driving the crystal with circularly polarized light, the team created a protected topological channel that keeps light on course.
The discovery points toward sturdier lasers, smarter optical chips, and future devices that could safeguard quantum information.
Relaying a message from point A to B can be as simple as flashing a thumbs-up at a stranger in an intersection, signaling them to proceed—nonverbal, clear, and universally understood. ...
Researchers uncover how COVID-19 may linger in cancer patients and affect treatment outcomes
2025-09-10
MINNEAPOLIS/ST. PAUL (09/10/2025) — New research from the University of Minnesota Medical School is providing important insights into how COVID-19 persists in cancer patients even long after testing positive. The findings were recently published in iScience.
During a peak of COVID-19 in 2020, there was concern around cancer patients who had contracted COVID-19 and developed severe inflammatory reactions that looked similar to autoimmune conditions. To better understand this phenomenon, researchers studied three cancer patients ...
Tiny metal figurines from Sardinia's Nuragic civilization in around 1,000 BC reveal extensive ancient Mediterranean metal trading networks
2025-09-10
Tiny metal figurines from Sardinia's Nuragic civilization in around 1,000 BC reveal extensive ancient Mediterranean metal trading networks
Article URL: http://plos.io/45QCTPq
Article title: Multiproxy analysis unwraps origin and fabrication biographies of Sardinian figurines: On the trail of metal-driven interaction and mixing practices in the early first millennium BCE
Author countries: Germany, Denmark, Italy
Funding: Grant agreement 23–1869 to HV, MKH, GS. Augustinus Foundation funding the Metals & Giants project. https://augustinusfonden.dk/en The foundation played no role in the study design, data collection and analysis, decision to publish, or preparation ...
Natural microfibers may degrade differently to synthetic materials under simulated sunlight exposure in freshwater and seawater conditions, with implications for how such pollutants affect aquatic lif
2025-09-10
Natural microfibers may degrade differently to synthetic materials under simulated sunlight exposure in freshwater and seawater conditions, with implications for how such pollutants affect aquatic life
Article URL: http://plos.io/3HS46t5
Article title: Structural evolution of microfibers in seawater and freshwater under simulated sunlight: A small- and wide-angle X-ray scattering study
Author countries: Italy, Austria
Funding: This work was partially funded by the European Union – Next Generation EU, Project Code: ECS00000041, Project Title: Innovation, Digitalization and Sustainability for the Diffused Economy in Central Italy ...
Indian new mums report better postpartum wellbeing when their own mum acts as their primary support - while women whose mother-in-law is the primary caregiver instead report significantly lower overal
2025-09-10
Indian new mums report better postpartum wellbeing when their own mum acts as their primary support - while women whose mother-in-law is the primary caregiver instead report significantly lower overall wellness
Article URL: https://plos.io/45Sz6RO
Article title: Investigating the role of family members in postnatal care: Evidence from mother-caregiver dyads in India
Author countries: U.S., India
Funding: The author(s) received no specific funding for this work. END ...
Young adult intelligence and education are correlated with socioeconomic status in midlife
2025-09-10
Educational attainment and intelligence, and to a smaller extent parental education and father’s occupational class, are associated with midlife socioeconomic status, according to a new study published September 10, 2025 in the open-access journal PLOS One by Erik Lykke Mortensen of University of Copenhagen, Denmark.
Socioeconomic status (SES)—a measure of individual differences in access to material and social resources—has long been linked with health, morbidity, and cognition. Previous studies ...
LAST 30 PRESS RELEASES:
Scientists create ChatGPT-like AI model for neuroscience to build one of the most detailed mouse brain maps to date
AI and omics unlock personalized drugs and RNA therapies for heart disease
2023 ocean heatwave ‘unprecedented but not unexpected’
Johns Hopkins researchers develop AI to predict risk of US car crashes
New drug combination offers hope for men with advanced prostate cancer
New discovery finds gene converts insulin-producing cells into blood-sugar boosters
Powerful and precise multi-color lasers now fit on a single chip
Scientists agree chemicals can affect behavior, but industry workers more reluctant about safety testing
DNA nanospring measures cellular motor power
Elsevier Foundation and RIKEN launch “Envisioning Futures” report: paving the way for gender equity and women’s leadership in Japanese research
Researchers discover enlarged areas of the spinal cord in fish, previously found only in four-limbed vertebrates
Bipolar disorder heterogeneity decoded: transforming global psychiatric treatment approaches
Catching Alport syndrome through universal age-3 urine screening
Instructions help you remember something better than emotions or a good night’s sleep
Solar energy is now the world’s cheapest source of power, a Surrey study finds
Scientists reverse Alzheimer’s in mice using nanoparticles
‘Good’ gut bacteria boosts placenta for healthier pregnancy
USC team demonstrates first optical device based on “optical thermodynamics”
Microplastics found to change gut microbiome in first human-sample study
Artificially sweetened and sugary drinks are both associated with an increased risk of liver disease, study finds
Plastic in the soil, but not as we know it: Biodegradable microplastics rewire carbon storage in farm fields
Yeast proteins reveal the secrets of drought resistance
Psychiatry, primary care, and OB/GYN subspecialties hit hardest by physician attrition
New Canadian study reveals where HIV hides in different parts of the body
Lidocaine poisonings rise despite overall drop in local anesthetic toxicity
Politics follow you on the road
Scientists blaze new path to fighting viral diseases
The mouse eye as a window to spotting systemic disease
AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs
FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials
[Press-News.org] Treating opioid addiction in jails improves treatment engagement, reduces overdose deaths and reincarcerationNIH-funded study demonstrates life-saving potential of providing medications for opioid use disorder in carceral settings